Skip to content
  • Home
  • About
Search
Close

MEDCOMMSNEWS

News, Views and Opinion – Headlines from the world of the pharmaceutical industry and MedComms, focusing on specialist medical education, medical communications and medical publishing activities

Data Transparency / Publications

Pharmaceutical companies’ policies on access to trial data, results, and methods: audit study

July 26, 2017July 28, 2017 Peter Llewellyn

From The BMJ – [Read more]

Share this:

  • Twitter
  • Facebook

Like this:

Like Loading...

Related

Post navigation

Previous Post
Cabell’s New Predatory Journal Blacklist: A Review
Next Post
Lucid group adds to its medical writing team

Specialist news and insights from: The Publication Plan for everyone interested in medical writing, the development of medical publications, and publication planning

How much can a single paper affect journal impact factor?

Does professional medical writing support impact the quality, ethics and timeliness of clinical trial reporting?

ISMPP poll: non-disclosure of possible COI by author ‒ what would you do?

CBI’s Medical Publications and Communications Forum

AMWA–EMWA–ISMPP joint position statement on predatory publishing

Archives

Index

Related service

MedComms Networking
MedComms Networking is a global initiative that facilitates networking and dialogue amongst individuals working in and around the pharmaceutical industry and MedComms, focusing on specialist medical education, medical communications and medical publishing activities. Why not sign up to our weekly newsletter and please, help spread the word amongst all relevant others.
Blog at WordPress.com.
Back to top
%d bloggers like this: